Volver al
artículo.
Referencias para el artículo
- Lees AM, Mok HYI, Lee RS, et al. Plant sterols as cholesterol-lowering agents:
clinical trials in patients with hypercholesterolemia and studies of sterol balance.
Atherosclerosis 1977;28:325-38.
- Pelletier X, Belbraouet S, Mirabel D, et al. A diet moderately enriched in
phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann
Nutr Metab 1995;39:291-5.
- Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al. Modulation of plasma lipid
levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res
2000;41:697-705.
- Grundy SM, Ahrens EH Jr, Davignon J. The interaction of cholesterol absorption
and cholesterol synthesis in man. J Lipid Res 1969;10:304-15 [review].
- Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled,
double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia.
Lancet 1995;345:1529-32.
- Kiriakidis S, Stathi S, Jha HC, et al. Fatty acid esters of sitosterol
3-glucoside from soybeans and tempeh (fermented soybeans) as antiproliferative
substances. J Clin Biochem Nutr 1997;22:139-47.
- Awad AB, Chan KC, Downie AC, Fink CS. Peanuts as a source of
ß-sitosterol, a sterol with anticancer properties. Nutr Cancer
2000;36:238–41.
- Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled,
double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia.
Lancet 1995;345:1529–32.
- Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled,
double-blind clinical trial of ß-sitosterol (phytosterol) for the treatment of benign
prostatic hyperplasia. Br J Urol 1997;80:427–32.